The latest price target for Crescent Capital BDC (NASDAQ:CCAP) was reported by Keefe, Bruyette & Woods on April 16, 2026. The analyst firm set a price target for $15.00 expecting CCAP to rise to within 12 months (a possible 12.28% upside). 11 analyst firms have reported ratings in the last year.

The latest analyst rating for Crescent Capital BDC (NASDAQ:CCAP) was provided by Keefe, Bruyette & Woods, and Crescent Capital BDC maintained their outperform rating.

There is no last upgrade for Crescent Capital BDC

The last downgrade for Crescent Capital BDC Inc happened on May 16, 2025 when Keefe, Bruyette & Woods changed their price target from $18.5 to $17 for Crescent Capital BDC Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Crescent Capital BDC, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Crescent Capital BDC was filed on April 16, 2026 so you should expect the next rating to be made available sometime around April 16, 2027.

While ratings are subjective and will change, the latest Crescent Capital BDC (CCAP) rating was a maintained with a price target of $15.50 to $15.00. The current price Crescent Capital BDC (CCAP) is trading at is $13.36, which is out of the analyst’s predicted range.